• $446.0M
    Market Cap
  • 87.05%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
2.0M
0.00%
2.0M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
0
N/A
Gross Profit
0
-100.00%
2.0M
0.00%
2.0M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-39.1M
+1.59%
-38.4M
+94.39%
-19.8M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
56.9M
+4.47%
54.5M
+66.32%
32.7M
N/A
Operating Profit
-56.9M
+4.47%
-54.5M
+77.14%
-30.7M
N/A
Interest Income
5.9M
-34.16%
8.9M
+210.73%
2.9M
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
5.9M
-34.16%
8.9M
+210.73%
2.9M
N/A
Total Nonoperating Income and Expense
5.9M
-34.16%
8.9M
+210.30%
2.9M
N/A
Income before Taxes
-56.9M
+4.47%
-54.5M
+77.14%
-30.7M
N/A
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-51.0M
+12.01%
-45.6M
+63.46%
-27.9M
N/A
Net Income from Continuing Operations Applicable to Common
-51.0M
+12.01%
-45.6M
+63.46%
-27.9M
N/A
Basic EPS and Net Income
-1.58
+8.97%
-1.45
-45.49%
-2.66
N/A
Diluted EPS and Net Income
-1.58
+8.97%
-1.45
-45.49%
-2.66
N/A
Basic Weighted Average Shares
32.3M
+3.17%
31.4M
+199.71%
10.5M
N/A
Diluted Weighted Average Shares
32.3M
+3.17%
31.4M
+199.71%
10.5M
N/A
Balance Sheet
Cash and Cash Equivalents
35.0M
-53.82%
75.8M
+0.93%
75.1M
N/A
Short-Term Investments
78.1M
+3.57%
75.4M
+281.67%
19.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
113.1M
-25.21%
151.3M
+59.38%
94.9M
N/A
Total Current Assets
116.4M
-23.81%
152.8M
+58.08%
96.6M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
0
-100.00%
7.4M
N/A
N/A
N/A
Total Assets
116.5M
-27.32%
160.3M
+65.70%
96.7M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.1M
+14.53%
4.5M
-21.22%
5.7M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
78,000
0.00%
78,000
-4.88%
82,000
N/A
Total Liabilities
5.1M
+14.53%
4.5M
-21.22%
5.7M
N/A
Retained Earnings
-346.3M
+17.28%
-295.3M
+18.25%
-249.7M
N/A
Total Stockholders Equity
111.4M
-28.51%
155.8M
+71.09%
91.1M
N/A
Total Shares Outstanding
567,494
N/A
0
N/A
0
N/A
Cash Flow
Cash from Operating Activities
-45.6M
+7.58%
-42.4M
+78.55%
-23.8M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
4.6M
+107.39%
-61.7M
-590.33%
12.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
275,000
-99.74%
104.8M
+21.65%
86.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-2,722.70%
N/A
N/A
N/A
Return on Assets
-36.88%
+4.01%
-35.46%
N/A
N/A
N/A
Return on Equity
-38.20%
+3.49%
-36.92%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
0.00%
N/A
N/A
N/A
Current Ratio
22.82
-33.47%
34.30
N/A
N/A
N/A
Cash Ratio
6.87
-59.68%
17.03
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow